Publications found:
73,128
Sort by:
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under ...
June 2020
98 pages
Myocardial Fibrosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Myocardial Fibrosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
87 pages
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
327 pages
Poliomyelitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Poliomyelitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Poliomyelitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
91 pages
Sicca Syndrome (Sjogren) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Sicca Syndrome (Sjogren) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Sicca Syndrome (Sjogren) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
189 pages
Toxoplasmosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Toxoplasmosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Toxoplasmosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
48 pages
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2020
US$ 2,000.00
... Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections and features dormant and discontinued projects. The guide covers therapeutics under ...
June 2020
60 pages
Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Anemia in Chronic Kidney Disease (Renal Anemia) (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Anemia in Chronic Kidney Disease (Renal Anemia) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
152 pages
Dengue Fever - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Dengue Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Dengue Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
179 pages
Female Contraception - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Female Contraception (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Contraception and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
92 pages
Gaucher Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gaucher Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Gaucher Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
105 pages
Meningitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Meningitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Meningitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
76 pages
Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Multiple Myeloma (Kahler Disease) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Multiple Myeloma (Kahler Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
2289 pages
Pertussis (Whooping Cough) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Pertussis (Whooping Cough) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pertussis (Whooping Cough) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
127 pages
Bullous Pemphigoid - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bullous Pemphigoid (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Bullous Pemphigoid and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
139 pages
Globoid Cell Leukodystrophy (Krabbe Disease) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Globoid Cell Leukodystrophy (Krabbe Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
77 pages
Ornithine-Transcarbamylase Deficiency - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ornithine-Transcarbamylase Deficiency (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Ornithine-Transcarbamylase Deficiency and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
53 pages
Graves Diseases - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Graves Diseases (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Graves Diseases and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
75 pages
Heart Transplant Rejection - Pipeline Review, H1 2020
US$ 2,000.00
... therapeutics under Development by Companies/Universities/Institutes, Heart Transplant Rejection - Pipeline Review, H1 2018 Reference Code: GMDHC10549IDBPublication Date: June 2018 Heart Transplant Rejection (Immunology) pipeline guide helps in identifying and tracking emerging players ...
June 2020
33 pages
Hyperinsulinemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hyperinsulinemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hyperinsulinemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
77 pages
Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H7N9 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
136 pages
Merkel Cell Carcinoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Merkel Cell Carcinoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Merkel Cell Carcinoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
535 pages
Middle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Middle East Respiratory Syndrome (MERS) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Middle East Respiratory Syndrome (MERS) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
134 pages
Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Pipeline Review, H1 2020
US$ 2,000.00
... Neurofibromatoses Type I (Von Recklinghausen’s Disease) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neurofibromatoses Type I (Von Recklinghausen’s Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
69 pages
Prosthetic joint infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Prosthetic joint infections (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Prosthetic joint infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
66 pages
Tinea pedis (Athlete Foot) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Tinea pedis (Athlete Foot) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tinea pedis (Athlete Foot) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
32 pages
Usher Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Usher Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Usher Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
60 pages
Wilson Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Wilson Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Wilson Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
65 pages
Zika Virus Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Zika Virus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Zika Virus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
274 pages
Presbyopia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Presbyopia (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Presbyopia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
60 pages
Global Telemedicine Market: Analysis By Specialties (Teledermatology, Teleradiology, Telepsychiatry, Others), By Component, By Region, By Country (2020 Edition): Market Insights, COVID-19 Impact, Competition and Forecast (2020-2025)
US$ 2,000.00
EXECUTIVE SUMMARY The Global Telemedicine Market was valued at USD 30.7 billion in the year 2019. With the increasing aging population and prevalence of chronic diseases, there is an increasing need...
June 2020
178 pages
5' Nucleotidase - Pipeline Review, H1 2020
US$ 3,500.00
5' Nucleotidase - Pipeline Review, H1 2020 SUMMARY According to the recently published report '5' Nucleotidase – Pipeline Review, H1 2020'; 5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or E...
June 2020
109 pages
Alpha 2C Adrenergic Receptor - Pipeline Review, H1 2020
US$ 3,500.00
Alpha 2C Adrenergic Receptor - Pipeline Review, H1 2020 SUMMARY Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) – Alpha-2C adrenergic recep...
June 2020
50 pages
Alpha N-Acetylglucosaminidase - Pipeline Review, H1 2020
US$ 3,500.00
Alpha N-Acetylglucosaminidase - Pipeline Review, H1 2020 SUMMARY Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) pipeline Target constitutes close to 8 molecul...
June 2020
54 pages
Alpha Synuclein - Pipeline Review, H1 2020
US$ 3,500.00
Alpha Synuclein - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Alpha Synuclein – Pipeline Review, H1 2020'; Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non...
June 2020
150 pages
Bcl 2 Like Protein 1 - Pipeline Review, H1 2020
US$ 3,500.00
Bcl 2 Like Protein 1 - Pipeline Review, H1 2020 SUMMARY Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) – Bcl-2-like protein 1 is a protein encoded by the BCL2L1 gene. It belongs t...
June 2020
61 pages
Ephrin Type B Receptor 4 - Pipeline Review, H1 2020
US$ 3,500.00
Ephrin Type B Receptor 4 - Pipeline Review, H1 2020 SUMMARY Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constit...
June 2020
49 pages
Integrin Alpha 4 - Pipeline Review, H1 2020
US$ 3,500.00
Integrin Alpha 4 - Pipeline Review, H1 2020 SUMMARY Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) pipeline Target constitutes close to 18 molecules. Th...
June 2020
105 pages
Integrin Beta 7 - Pipeline Review, H1 2020
US$ 3,500.00
Integrin Beta 7 - Pipeline Review, H1 2020 SUMMARY Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) – Integrin beta-7 is an integrin protein encoded by the ITGB7 gene. It interacts with t...
June 2020
64 pages
Leptin Receptor - Pipeline Review, H1 2020
US$ 3,500.00
Leptin Receptor - Pipeline Review, H1 2020 SUMMARY Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) pipeline Target constitutes close to 8 molecules. The latest report Leptin Receptor – Pipe...
June 2020
54 pages
P2X Purinoceptor 3 - Pipeline Review, H1 2020
US$ 3,500.00
P2X Purinoceptor 3 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'P2X Purinoceptor 3 – Pipeline Review, H1 2020'; P2X Purinoceptor 3 (P2RX3) pipeline Target constitut...
June 2020
67 pages
